Pharmaceutical Technology on MSN
UK biotech could be bound for recovery, BIA report reveals
With an uptick and increasingly even spread of capital across the space, the BIA’s Martin Turner is optimistic for British ...
U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a doctor’s office. Ikarovec’s IKAR-003 is currently in preclinical ...
Hosted on MSN
UK biotech financing jumps 18% as firms eye R&D push
UK biotech companies raised £552 million in equity financing in Q1 2026, marking an 18% increase from the prior quarter, with venture capital up 17%. The capital was distributed among more firms than ...
Novartis AG will pay UK biotech Relation Therapeutics Ltd. as much as $1.7 billion to help find drug targets to treat allergic diseases. The Swiss drugmaker will pay $55 million upfront to combine its ...
LONDON, Jan. 9, 2026 /PRNewswire/ -- M&G Investments (M&G) today announces that it has led a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results